Jan 8, 2026
Where State Licensing Is Heading in 2027
Licensure is reaching entities that never touch product, ownership is under closer scrutiny, and fees are rising. What that means for 2027.
2026 brought a steady series of changes to state licensing requirements. The individual developments were specific to particular states, but taken together they point in a consistent direction for 2027.
1. States Are Licensing Entities That Never Touch Product
The clearest trend is the extension of licensure to companies defined by ownership or contract rather than physical activity. Illinois began requiring licensure of virtual wholesale distributors in July 2026. South Carolina created a separate permit for contract manufacturers and distinguishes it from manufacturer and virtual manufacturer permits. Companies that have relied on not handling product as the basis for not holding a license should expect that basis to narrow further.
2. Scrutiny Is Shifting to People and Ownership
Delaware now requires fingerprinting of key personnel, including owners above a 10 percent threshold at privately held companies, and terminates licenses automatically on a change in controlling interest. South Carolina will require nonresident outsourcing facilities to designate a pharmacist-in-charge licensed in South Carolina by June 30, 2027. Boards are increasingly asking not only what a facility does, but who controls it and who is accountable for it.
3. The Cost of Licensure Is Rising
Virginia raised fees for manufacturers, distributors, logistics providers and outsourcing facilities in September 2026, in several cases more than doubling them. California and Alabama have proposed increases of their own. For companies with national portfolios, fee changes are now a recurring budget item rather than a rare event.
4. Federal Changes Will Reach State Systems
FDA extended the DSCSA exemption for small dispensers to November 2027, leaving one more year of mixed interoperability across the supply chain. Its final rule on the 12-digit National Drug Code takes effect in 2033, and the transition will eventually touch every state program that relies on the NDC. FDA's proposed national standards for wholesale distributor and third-party logistics provider licensure, published in 2022, have not been finalized, so state requirements continue to govern.
What This Means for 2027
Taken together, these developments favor companies that treat licensing as an ongoing function rather than a series of one-time filings. In 2027, that means:
Revisiting prior decisions that no license was required
Identifying key personnel and owners before the next application or renewal
Treating any change in ownership as a potential licensure event
Budgeting for higher renewal fees across the portfolio
Confirming that contract manufacturers and logistics providers are keeping pace
Key Takeaway
No single change in 2026 transformed state licensing. The cumulative effect is that requirements now reach more entities, more people and more transactions than they did a year ago, and that trend shows no sign of reversing.